Shares of Gentiva Health Services (NASDAQ:GTIV) opened at 13.67 on Wednesday. Gentiva Health Services has a one year low of $7.35 and a one year high of $14.50. The stock has a 50-day moving average of $8.81 and a 200-day moving average of $10.57. The company’s market cap is $503.6 million.
Gentiva Health Services (NASDAQ:GTIV) last announced its earnings results on Wednesday, May 7th. The company reported $0.13 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.11 by $0.02. The company had revenue of $487.50 million for the quarter, compared to the consensus estimate of $491.51 million. During the same quarter in the prior year, the company posted $0.23 earnings per share. The company’s quarterly revenue was up 17.3% on a year-over-year basis. On average, analysts predict that Gentiva Health Services will post $0.90 earnings per share for the current fiscal year.
A number of other analysts have also recently weighed in on GTIV. Analysts at Zacks upgraded shares of Gentiva Health Services from an “underperform” rating to a “neutral” rating in a research note on Monday. They now have a $14.00 price target on the stock. Separately, analysts at Credit Suisse reiterated an “underperform” rating on shares of Gentiva Health Services in a research note on Friday, May 16th. They now have a $14.00 price target on the stock, up previously from $9.00. Finally, analysts at CRT Capital raised their price target on shares of Gentiva Health Services from $10.50 to $16.00 in a research note on Friday, May 16th. They now have a “buy” rating on the stock. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the company. Gentiva Health Services currently has an average rating of “Hold” and an average price target of $14.50.
Gentiva Health Services, Inc (NASDAQ:GTIV) is engaged in providing home health services and hospice services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.